Live Breaking News & Updates on Hase Dmac Ca25253x2077

Stay updated with breaking news from Hase dmac ca25253x2077. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results

Conference Call and Webcast May 16 at 8:00 am Eastern Time / 7:00 am Central Time

Company Completed In-Use Study, Results Support Proposed ReMEDy2 IV Dose Revision

Company Completed a Phase 1C. | May 15, 2023 ....

United States , South Korea , Rick Pauls , Kirsten Gruis , Diamedica Therapeutics Inc , Drug Administration , Research Associates Group , Exchange Commission , Diamedica Therapeutics , Daylight Time , Acute Ischemic Stroke , Clinical Hold , Chief Executive , Chief Medical , Chief Business , Medica Management , Fast Track Designation , Medica Therapeutics , Securities Litigation Reform Act , Consolidated Statements , Months Ended March , Diamedica Therapeutics Inc Stock Exchange , Press Release , Hase Dmac Ca25253x2077 ,